Skip to main content
Accredited official statistics

Gram-negative, MRSA and MSSA bacteraemia and C. difficile infections: annual epidemiological reports 2022 to 2025

Trends in E. coli, Klebsiella spp., P. aeruginosa, MRSA and MSSA bacteraemia and C. difficile infections by financial year, from 2022 to 2025.

Updates to this page

From:
UK Health Security Agency
Published:
10 July 2014
Last updated:
24 September 2026
Show all updates

  1. A link to the new annual epidemiological report page has been added.

  2. Removed survey callout box.

  3. Added annual epidemiological commentary up to and including the financial year April 2024 to March 2025.

  4. Added survey requests.

  5. Added annual epidemiological commentary up to and including the financial year April 2023 to March 2024.

  6. Corrected errors, as detailed in the 'Corrections to these statistics' section of the main 2022 to 2023 report.

  7. Added annual epidemiological commentary up to and including the financial year April 2022 to March 2023. Archived April 2021 to March 2022 data.

  8. Added annual epidemiological commentary up to and including the financial year April 2021 to March 2022. Archived April 2020 to March 2021 data.

  9. Added annual epidemiological commentary up to and including the financial year April 2020 to March 2021. Archived April 2019 to March 2020 data.

  10. Added annual epidemiological commentary up to and including the financial year April 2019 to March 2020, archived April 2018 to March 2019 data.

  11. Added amended commentary with corrected values for age and sex rates and population in tables 28 and 29 on page 60.

  12. Added annual epidemiological commentary up to and including the financial year April 2018 to March 2019, archived April 2017 to March 2018 data.

  13. Archived all historic annual reports, added headline information link and updated the headline information for all data collections, for financial year 2017 to 2018, to correct data for hospital/community-onset comparisons.

  14. Added annual epidemiological commentary up to and including the financial year April 2017 to March 2018.

  15. Added annual epidemiological commentary up to and including the financial year April 2016 to March 2017.

  16. Added annual epidemiological commentary up to and including the financial year April 2015 to March 2016.

  17. Annual epidemiological commentary up to and including the financial year April 2014 to March 2015 added.

  18. First published.

Accredited official statistics

Applies to England

Documents

Annual reports and data from 2025 to 2026

https://www.gov.uk/government/collections/gram-negative-mrsa-and-mssa-bacteraemia-and-c-difficile-infections-annual-epidemiological-commentaries

Annual epidemiological commentary: Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2024 to 2025

HTML

Accompanying data for Gram-negative, MRSA and MSSA bacteraemia and C. difficile infection data, up to and including financial year 2024 to 2025

ODS, 522 KB

This file is in an OpenDocument format

MRSA, MSSA and Gram-negative bacteraemia and CDI: infographics for England, financial year 2024 to 2025

HTML

Annual epidemiological commentary: Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2023 to 2024

HTML

Accompanying data for Gram-negative, MRSA and MSSA bacteraemia and C. difficile infection data, up to and including financial year 2023 to 2024

Ref: GOV-17281

ODS, 464 KB

This file is in an OpenDocument format

MRSA, MSSA and Gram-negative bacteraemia and CDI: infographics for England, financial year 2023 to 2024

Ref: GOV-17281

HTML

Annual epidemiological commentary: Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2022 to 2023

Ref: GOV-16212

HTML

Accompanying data for Gram-negative, MRSA and MSSA bacteraemia and C. difficile infection data, up to and including financial year 2022 to 2023

Ref: GOV-16212

ODS, 257 KB

This file is in an OpenDocument format

MRSA, MSSA and Gram-negative bacteraemia and CDI: infographics for England, financial year 2022 to 2023

Ref: GOV-15486

HTML

Details

Annual reports and data from 2025 to 2026 onwards are available from the annual epidemiological commentaries collection page.

These official statistics were independently reviewed by the Office for Statistics Regulation in May 2022. They comply with the standards of trustworthiness, quality and value in the Code of Practice for Statistics and should be labelled ‘accredited official statistics’. Accredited official statistics are called National Statistics in the Statistics and Registration Service Act 2007. Further explanation of accredited official statistics can be found on the Office for Statistics Regulation website.

View the pre-release access list for this statistical release.

Financial year data

The following financial year data is included in the latest annual epidemiological commentary for Escherichia coli (E. coli), Klebsiella species (Klebsiella spp.), Pseudomonas aeruginosa (P. aeruginosa), meticillin- resistant Staphylococcus aureus (MRSA), meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia and Clostridioides difficile infection (CDI).

  • E. coli bacteraemia: April 2012 to March 2025
  • Klebsiella spp. bacteraemia: April 2017 to March 2025
  • P. aeruginosa bacteraemia: April 2017 to March 2025
  • MRSA bacteraemia: April 2007 to March 2025
  • MSSA bacteraemia: April 2011 to March 2025
  • C. difficile infection: April 2007 to March 2025

Annual trust and sub-integrated care board tables

For annual publications for previous financial years please see:

Enquiries or feedback

To request copies of the report in alternative formats, please contact publications@ukhsa.gov.uk

For any other enquiries or feedback, contact mandatory.surveillance@ukhsa.gov.uk

Sign up for emails or print this page

Related content